Medication
M-Alendronate
DIN 02529394 · Mantra Pharma Inc Likely a generic
What it is
- Active ingredients
- Alendronic Acid — 70 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2023-05-01
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Fosamax
- Apo-Alendronate
- Teva-Alendronate
- Riva-Alendronate
- PMS-Alendronate-FC
- Alendronate
- ALENDRONATE-70
- Alendronate
- Ach-Alendronate
- Auro-Alendronate
- Jamp Alendronate Sodium
- AG-Alendronate Sodium
- Nra-Alendronate
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Musculo-skeletal system
- ATC code
- M05BA04
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of M05BA04, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.